Swiss National Bank Surmodics Inc Transaction History

Swiss National Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$17.13 - $38.52 $59,955 - $134,820	-3,500 Reduced 10.36%	30,300 $690,000
Q4 2022 Feb 08, 2023	BUY	$29.44 - $37.31 $26,496 - $33,579	900 Added 2.74%	33,800 $1.15 Million
Q1 2022 May 09, 2022	BUY	$40.68 - $49.72 $105,768 - $129,272	2,600 Added 8.58%	32,900 $1.49 Million
Q2 2021 Aug 06, 2021	SELL	$51.29 - $59.15 $46,161 - $53,235	-900 Reduced 2.88%	30,300 $1.64 Million
Q1 2021 May 07, 2021	BUY	$42.18 - $56.07 $29,526 - $39,249	700 Added 2.3%	31,200 $1.75 Million
Q2 2020 Aug 05, 2020	BUY	$31.07 - $44.74 $133,601 - $192,382	4,300 Added 16.41%	30,500 $1.32 Million
Q1 2020 May 08, 2020	BUY	$22.46 - $42.24 $8,984 - $16,896	400 Added 1.55%	26,200 $873,000
Q4 2019 Feb 06, 2020	BUY	$39.01 - $47.51 $31,208 - $38,008	800 Added 3.2%	25,800 $1.07 Million
Q2 2019 Aug 02, 2019	BUY	$38.23 - $47.43 $22,937 - $28,458	600 Added 2.46%	25,000 $1.08 Million
Q1 2019 May 10, 2019	BUY	$41.26 - $58.35 $33,008 - $46,680	800 Added 3.39%	24,400 $1.06 Million
Q4 2018 Feb 13, 2019	BUY	$44.93 - $73.38 $35,944 - $58,704	800 Added 3.51%	23,600 $1.12 Million
Q3 2017 Nov 03, 2017	BUY	$24.5 - $31.1 $558,600 - $709,080	22,800	22,800 $707,000

126

11.7M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.